• No results found

How I Treat

N/A
N/A
Protected

Academic year: 2022

Share "How I Treat"

Copied!
10
0
0

Laster.... (Se fulltekst nå)

Fulltekst

Referanser

RELATERTE DOKUMENTER

Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical

To further examine the effect of TKIs or IFNα treatment on primary patient derived cells, cryopreserved bone marrow-derived cells from six chronic phase CML patients and

While bone marrow stem cells are the preferred stem cell source in acquired aplastic anemia, peripheral blood stem cells can be con- sidered in the case of graft failure [9]..

NCT01862965 II Prednisone + Everolimus for treating patients with moderate to severe cGvHD TKI, tyrosine kinase inhibitor; aGvHD, acute graft versus host disease; cGvHD, chronic

Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood. Tidsskr

Bone marrow involvement with eosinophilia and increased IgG4 + plasma cells is rare and may be absent even in patients with marked serum

We have established the first in man clinical study with treatment with mesenchymal stromal cells from the bone marrow of patients with chronic coronary artery disease and

In this issue of Blood , Kong et al show that bone marrow (BM) endothelial progenitor cells (EPCs) in patients with corticosteroid-resistant immune thrombocytopenia (ITP) are